Vanguard Personalized Indexing Management LLC Acquires 2,795 Shares of Exponent, Inc. $EXPO

Vanguard Personalized Indexing Management LLC lifted its holdings in shares of Exponent, Inc. (NASDAQ:EXPOFree Report) by 22.5% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 15,207 shares of the business services provider’s stock after acquiring an additional 2,795 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Exponent were worth $1,136,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the business. Brooklyn Investment Group lifted its holdings in Exponent by 10,200.0% during the 1st quarter. Brooklyn Investment Group now owns 309 shares of the business services provider’s stock valued at $25,000 after purchasing an additional 306 shares during the last quarter. Bessemer Group Inc. raised its position in shares of Exponent by 103.3% in the first quarter. Bessemer Group Inc. now owns 681 shares of the business services provider’s stock valued at $55,000 after purchasing an additional 346 shares during the period. SVB Wealth LLC bought a new position in shares of Exponent in the first quarter valued at about $80,000. Caitong International Asset Management Co. Ltd lifted its stake in shares of Exponent by 8,092.9% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,147 shares of the business services provider’s stock worth $93,000 after buying an additional 1,133 shares during the last quarter. Finally, Covestor Ltd boosted its holdings in shares of Exponent by 43.7% during the 1st quarter. Covestor Ltd now owns 1,785 shares of the business services provider’s stock worth $145,000 after buying an additional 543 shares during the period. 92.37% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “hold (c-)” rating on shares of Exponent in a report on Wednesday, October 8th. One research analyst has rated the stock with a Hold rating, According to MarketBeat, the company presently has an average rating of “Hold”.

View Our Latest Research Report on EXPO

Exponent Stock Performance

EXPO opened at $67.50 on Friday. The stock has a fifty day moving average of $69.57 and a 200-day moving average of $73.75. The company has a market capitalization of $3.41 billion, a P/E ratio of 33.75 and a beta of 0.91. Exponent, Inc. has a fifty-two week low of $63.81 and a fifty-two week high of $113.36.

Exponent (NASDAQ:EXPOGet Free Report) last issued its quarterly earnings data on Thursday, July 31st. The business services provider reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.04. The business had revenue of $132.87 million during the quarter, compared to analysts’ expectations of $130.82 million. Exponent had a net margin of 18.35% and a return on equity of 24.19%. The business’s revenue was up 7.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.57 EPS. On average, equities research analysts predict that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.

Exponent Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Friday, September 5th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.8%. The ex-dividend date was Friday, September 5th. Exponent’s payout ratio is 60.00%.

Insider Activity at Exponent

In related news, VP Joseph Sala sold 1,595 shares of the stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $70.64, for a total transaction of $112,670.80. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Catherine Corrigan sold 4,930 shares of the firm’s stock in a transaction on Wednesday, October 15th. The stock was sold at an average price of $66.82, for a total value of $329,422.60. Following the transaction, the chief executive officer owned 82,753 shares in the company, valued at approximately $5,529,555.46. This trade represents a 5.62% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 16,326 shares of company stock valued at $1,133,059. 1.60% of the stock is currently owned by corporate insiders.

About Exponent

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Further Reading

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPOFree Report).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.